Holmes Biopharma, Inc.: Omaha Operations Resume

SCOTTSDALE, ARIZONA announces that its clinic in Omaha Nebraska has resumed operations with business as usual. This brief interruption has not affected the ability of the Omaha clinic to carry out services to clients and study participants.

The Company intends to operate the Omaha clinic at full capacity. "We can assure our clients and shareholders that we will continue to provide the highest quality of products and services", stated John F. Metcalfe, President CEO Holmes Biopharma, Inc.

On behalf of the Board of Directors

John F. Metcalfe President, CEO

Certain statements in this press release constitute "forward looking statements" within the meaning of the United States Securities Legislation. The Company's actual results could differ from those in the forward-looking statements. Do not construe this information as investment advice. This is not a solicitation to buy or sell securities. This does not purport to be a complete analysis of the Company. Investing in securities is speculative and carries a high degree of risk. Past performance does not guarantee future results. Readers should consult their own independent advisers with any investment, including any contemplated investment. All information contained in this press release should be independently investigated. This press release contains forward-looking statements. These remarks involve risks and uncertainties. Risks are not limited to quarterly fluctuations in results or the companies' management of growth and competition. Other risks are detailed in the Company's SEC filings. Actual results may differ materially from such information set forth herein.

Contacts: Holmes Biopharma, Inc. John F. Metcalfe President, CEO 1-800-778-4990 Email: ir@holmesbiopharma.com Website: www.holmesbiopharma.com

Swiftsure (CE) (USOTC:HLMB)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024